Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

9

Revenue 2017

Gilead Sciences

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.

Gilead Sciences, Inc.

Daily brief: Novartis spends big on ezcema,

Daily brief: Novartis spends big on ezcema,

Kite invests in Gadeta’s gamma delta T cell receptors. Gilead acquired Kite last year for its leadership in cutting edge CAR-T drugs – and the now approved Yescarta – and now ... Alessandro Riva, MD, Gilead's executive vice president, Oncology

MaxCyte gets green light for solid tumour cell therapy

MaxCyte gets green light for solid tumour cell therapy The current generation of CAR-T therapies – namely Novartis’Kymriah (tisagenlecleucel) and Gilead/Kite’s Yescarta (axicabtagene ciloleucel) – use engineered T cells harvested from blood, which have to be expanded in

Gilead’s Biktarvy gets European approval, setting up battle with GSK

Gilead’s Biktarvy gets European approval, setting up battle with GSK The drug could offset Gilead's disappointing hep C franchise. Gilead has gained European approval for its new HIV combination therapy Biktarvy, hot on the heels of GSK's rival Juluca. ... The single tablet regimen (STR) is a combination of integrase

Trial data suggest Abivax’ drug may clear latent HIV

Trial data suggest Abivax’ drug may clear latent HIV Other companies are also pursuing eradication strategies for HIV, including Gilead Sciences which reported encouraging data from an animal study earlier this year indicating that a two-drug regimen was able

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics